High dose brachytherapy as monotherapy for intermediate risk prostate cancer

Journal of Urology

Volumn 187, Issue 1, 2012, Pages 109-116

  Rogers, C Leland ^a   Alder, Stephen C ^b   Rogers, R Legrand ^c   Hopkins, Scott A ^d   Platt, McKay L ^e   Childs, Lane C ^d   Crouch, Ronald H ^f   Hansen, Roger S ^a   Hayes, John K ^a  

^a GammaWest Cancer Services   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c School of Medicine   (United States)

^d Westen Urological   (United States)

^e Central Utah Urology   (United States)

^f Urology Associates   (United States)

Author keywords

brachytherapy; mortality; neoplasm staging; prostate; prostatic neoplasms

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; ERECTILE DYSFUNCTION; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIPHERAL NEUROPATHY; POTENCY DISORDER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RECTUM DISEASE; RETROSPECTIVE STUDY; STROKE; TRANSURETHRAL RESECTION; TREMOR; TUMOR VOLUME; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 83555168196     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.09.050     Document Type: Article

References (30)

1. A. Bill-Axelson, L. Holmberg, M. Ruutu Scandinavian Prostate Cancer Group Study No. 4 Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977
2. W.U. Shipley, P.T. Scardino, and D.S. Kaufman Treatment of early stage prostate cancer: advising patients with early prostatic cancer on their treatment decision N.J. Vogelzang, P.T. Scardino, W.U. Shipley, Comprehensive Textbook of Genitourinary Oncology 3rd ed. 2006 Lippincott Williams & Wilkins Philadelphia 153 157
3. J. Crook, H. Lukka, and L. Klotz Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer CMAJ 164 2001 975
4. H. Ragde, L.J. Korb, and A.A. Elgamal Modern prostate brachytherapy: prostate specific antigen results in 219 patients with up to 12 years of observed follow-up Cancer 89 2000 135
5. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy >72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1T2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25
6. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer S JAMA 280 1998 969
7. A. Widmark, O. Klepp, A. Solberg Scandinavian Prostate Cancer Group Study No. 7 and the Swedish Association for Urological Oncology No. 3 Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301
8. A.V. D'Amico, B.J. Moran, and M.H. Braccioforte Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease J Clin Oncol 27 2009 3923
9. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologic T3N0M0 prostate cancer significantly reduces risk of metastasis and improves survival: long-term followup of a randomized trial J Urol 181 2009 956
10. A.V. D'Amico, M.H. Chen, and A.A. Renshaw Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289
11. J.R. Sathya, I.R. Davis, and J.A. Julian Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192
12. L. Potters, C. Morgenstern, and E. Calugaru 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 173 2005 1562
13. G.S. Merrick, W.M. Butler, and K.E. Wallner Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 61 2005 32
14. A.A. Martinez, D.J. Demanes, and R. Galalae Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime Int J Radiat Oncol Biol Phys 62 2005 1322
15. C.E. Vargas, R. Galalae, and J. Demanes Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation Int J Radiat Oncol Biol Phys 63 2005 1474
16. E.A. Klein, J. Ciezki, and P.A. Kupelian Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? Semin Urol Oncol 27 2009 67
17. B.R. Pieters, D.Z. de Back, and C.C.E. Koning Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review Radiother Oncol 93 2009 168
18. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HD brachytherapy and IMRT Brachytherapy 9 2010 313
19. P.J. Hoskin, K. Motohashi, and P. Bownes High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial Radiother Oncol 84 2007 114
20. G.S. Merrick, M.W. Butler, and R.W. Galbreath Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1T3 prostate cancer Int J Radiat Oncol Biol Phys 51 2001 41
21. H. Thames, D. Kuban, and L. Levy Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated with external beam radiotherapy between 1986 and 1995 Int J Radiat Oncol Biol Phys 57 2003 929
22. L.B. Marks, P.R. Carroll, and T.C. Dugan The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy Int J Radiat Oncol Biol Phys 31 1995 1257
23. R.C. Rosen, J.C. Cappelleri, and M.D. Smith Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319
24. E.L. Rhoden, C. Telöken, and P.R. Sogari The use of the simplified index of erectile function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction Int J Impot Res 14 2002 245
25. M.W. Skwarchuk, A. Jackson, and M.J. Zelefsky Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response Int J Radiat Oncol Biol Phys 47 2000 103
26. D.F. Paulson, G.H. Lin, and W. Hinshaw Radical surgery versus radiotherapy for adenocarcinoma of the prostate J Urol 128 1982 502
27. G.W. Hull, F. Rabbani, and F. Abbas Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528
28. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327
29. A.V. Taira, G.S. Merrisk, and R.W. Galbreath Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy Int J Radiat Oncol Biol Phys 76 2010 349
30. J.M. Crook, A. Gomez-Iturriaga, and K. Wallace Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial J Clin Oncol 29 2010 362